These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 25255814)
1. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. Xu L; Li M; Wang M; Yan D; Feng G; An G BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814 [TBL] [Abstract][Full Text] [Related]
2. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. Luo X; Stock C; Burwinkel B; Brenner H PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963 [TBL] [Abstract][Full Text] [Related]
3. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
5. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
6. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance. Sahami-Fard MH; Kheirandish S; Sheikhha MH Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
9. Paired design study by real-time PCR: miR-378* and miR-145 are potent early diagnostic biomarkers of human colorectal cancer. Peng J; Xie Z; Cheng L; Zhang Y; Chen J; Yu H; Li Z; Kang H BMC Cancer; 2015 Mar; 15():158. PubMed ID: 25896668 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150 [TBL] [Abstract][Full Text] [Related]
11. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209 [TBL] [Abstract][Full Text] [Related]
12. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer. Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735 [TBL] [Abstract][Full Text] [Related]
13. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372 [TBL] [Abstract][Full Text] [Related]
14. A panel of microRNA signature in serum for colorectal cancer diagnosis. Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881 [TBL] [Abstract][Full Text] [Related]
15. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750 [TBL] [Abstract][Full Text] [Related]
16. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
17. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. Yong FL; Law CW; Wang CW BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639 [TBL] [Abstract][Full Text] [Related]
18. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530 [TBL] [Abstract][Full Text] [Related]
19. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Yuan D; Li K; Zhu K; Yan R; Dang C Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978 [TBL] [Abstract][Full Text] [Related]
20. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]